392 related articles for article (PubMed ID: 15305853)
61. Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose Administration.
Porażka J; Szałek E; Połom W; Czajkowski M; Grabowski T; Matuszewski M; Grześkowiak E
Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):579-584. PubMed ID: 30778911
[TBL] [Abstract][Full Text] [Related]
62. A disposition kinetic study of tramadol in rat perfused liver.
Rouini MR; Ghazi-Khansari M; Ardakani YH; Dasian Z; Lavasani H
Biopharm Drug Dispos; 2008 May; 29(4):231-5. PubMed ID: 18348341
[TBL] [Abstract][Full Text] [Related]
63. Postmenstrual age and CYP2D6 polymorphisms determine tramadol o-demethylation in critically ill neonates and infants.
Allegaert K; van Schaik RH; Vermeersch S; Verbesselt R; Cossey V; Vanhole C; van Fessem M; de Hoon J; van den Anker JN
Pediatr Res; 2008 Jun; 63(6):674-9. PubMed ID: 18317231
[TBL] [Abstract][Full Text] [Related]
64. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.
Tzvetkov MV; Saadatmand AR; Lötsch J; Tegeder I; Stingl JC; Brockmöller J
Clin Pharmacol Ther; 2011 Jul; 90(1):143-50. PubMed ID: 21562485
[TBL] [Abstract][Full Text] [Related]
65. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
Yancey MF; Merritt DA; Lesman SP; Boucher JF; Michels GM
J Vet Pharmacol Ther; 2010 Apr; 33(2):162-71. PubMed ID: 20444041
[TBL] [Abstract][Full Text] [Related]
66. Pharmacokinetic/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: role of cytochrome P450 2D activity.
Garrido MJ; Sayar O; Segura C; Rapado J; Dios-Vieitez MC; Renedo MJ; Troconiz IF
J Pharmacol Exp Ther; 2003 May; 305(2):710-8. PubMed ID: 12606644
[TBL] [Abstract][Full Text] [Related]
67. Pharmacokinetic profile of injectable tramadol in the koala (Phascolarctos cinereus) and prediction of its analgesic efficacy.
Kimble B; Vogelnest L; Valtchev P; Govendir M
PLoS One; 2021; 16(3):e0247546. PubMed ID: 33657107
[TBL] [Abstract][Full Text] [Related]
68. Preliminary pharmacokinetics of tramadol hydrochloride after administration via different routes in male and female B6 mice.
Evangelista Vaz R; Draganov DI; Rapp C; Avenel F; Steiner G; Arras M; Bergadano A
Vet Anaesth Analg; 2018 Jan; 45(1):111-122. PubMed ID: 29066180
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of tramadol human pharmacokinetics and safety after co-administration of magnesium ions in randomized, single- and multiple-dose studies.
Rudzki PJ; Jarus-Dziedzic K; Filist M; Gilant E; Buś-Kwaśnik K; Leś A; Sasinowska-Motyl M; Nagraba Ł; Bujalska-Zadrożny M
Pharmacol Rep; 2021 Apr; 73(2):604-614. PubMed ID: 33686610
[TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers.
Ardakani YH; Rouini MR
Biopharm Drug Dispos; 2007 Dec; 28(9):527-34. PubMed ID: 17891748
[TBL] [Abstract][Full Text] [Related]
71. Oral Coadministration of Fluconazole with Tramadol Markedly Increases Plasma and Urine Concentrations of Tramadol and the
Perez Jimenez TE; Kukanich B; Joo H; Mealey KL; Grubb TL; Greene SA; Court MH
Drug Metab Dispos; 2019 Jan; 47(1):15-25. PubMed ID: 30366901
[TBL] [Abstract][Full Text] [Related]
72. Clinical pharmacology of clemastine in healthy dogs.
Hansson H; Bergvall K; Bondesson U; Hedeland M; Törneke K
Vet Dermatol; 2004 Jun; 15(3):152-8. PubMed ID: 15214951
[TBL] [Abstract][Full Text] [Related]
73. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers.
Li Q; Wang R; Guo Y; Wen S; Xu L; Wang S
J Clin Pharm Ther; 2010 Apr; 35(2):239-47. PubMed ID: 20456744
[TBL] [Abstract][Full Text] [Related]
74. Simultaneous analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol enantiomers in rat plasma by high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.
Godoy AL; De Moraes NV; Martinez EZ; Carvalho TM; Marques MP; Lanchote VL
Chirality; 2011 Apr; 23(4):287-93. PubMed ID: 21384434
[TBL] [Abstract][Full Text] [Related]
75. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J; Weihe P; Brosen K
Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
[TBL] [Abstract][Full Text] [Related]
76. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
77. Pharmacokinetics of hydrocodone and tramadol administered for control of postoperative pain in dogs following tibial plateau leveling osteotomy.
Benitez ME; Roush JK; KuKanich B; McMurphy R
Am J Vet Res; 2015 Sep; 76(9):763-70. PubMed ID: 26309104
[TBL] [Abstract][Full Text] [Related]
78. Population pharmacokinetic analysis of tramadol and
Lee J; Yoo HD; Bae JW; Lee S; Shin KH
Drug Des Devel Ther; 2019; 13():1751-1761. PubMed ID: 31213765
[No Abstract] [Full Text] [Related]
79. Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
J Vet Pharmacol Ther; 2007 Feb; 30(1):32-6. PubMed ID: 17217398
[TBL] [Abstract][Full Text] [Related]
80. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
